Effects of the new angiotensin-converting enzyme inhibitor, ramipril, in patients with essential hypertension-Reference-Cited by-同舟云学术

Effects of the new angiotensin-converting enzyme inhibitor, ramipril, in patients with essential hypertension

Published:1986-06 Issue:12 Volume:64 Page:558-562
ISSN:0023-2173
Container-title:Klinische Wochenschrift
language:en
Short-container-title:Klin Wochenschr

Author:

Stumpe K. O.,Overlack A.,Kolloch R.,Schatz J.,Witte P. U.,Pahnke K.

Publisher

Springer Science and Business Media LLC

Subject

General Medicine,Genetics(clinical),Drug Discovery,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1007/BF01735319.pdf

Reference20 articles.

1. Becker RHA, Schölkens BA, Metzger H, Schulze KJ (1984) Pharmacological properties of the new orally active converting enzyme inhibitor HOE 498. Arzneimittelforsch 34(II):1411–1416

2. Cody RJ, Tarazi RC, Bravo EL, Fouad FM (1979) Hemodynamics of an orally-active converting enzyme inhibitor (SQ 14,225) in hypertensive patients. Clin Sci Mol Med 55:453–459

3. Cushman DW, Cheung HS (1971) Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol 20:1637–1648

4. Cushman DW, Cheung HS, Sabo EF, Ondetti MA (1977) Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids. Biochemistry 16: 5484–5491

5. Davis JO, Freeman RH (1976) Mechanisms regulating renin release. Physiol Rev 56:1–56

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The combination of valsartan and ramipril protects against blood vessel injury and lowers blood pressure;Journal of Pharmaceutical Investigation;2016-03-23

2. Ramipril;Cardiovascular Drug Reviews;2007-04-02

3. Choosing the Right ACE Inhibitor;Drugs;1995-04

4. Dose-response relationships with antihypertensive drugs;Pharmacology & Therapeutics;1992-01

5. Ramipril;Drugs;1990-01